{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T00:14:01Z","timestamp":1698970441014},"reference-count":70,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2010,4,20]],"date-time":"2010-04-20T00:00:00Z","timestamp":1271721600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Internal Medicine"],"published-print":{"date-parts":[[2010,8]]},"abstract":"<jats:p><jats:bold>Abstract.\u2002<\/jats:bold> Schulman S (McMaster University, Hamilton, ON, Canada; and Karolinska University Hospital, Stockholm, Sweden). New aspects on treatment modalities for thromboembolic episodes (Review). <jats:italic>J Intern Med<\/jats:italic> 2010; <jats:bold>268<\/jats:bold>: 109\u2013119.<\/jats:p><jats:p>Venous thromboembolism (VTE) has been treated with a glycosaminoglycan, followed by a vitamin K antagonist during the past 60\u2003years. During the past two decades the glycosaminoglycans have undergone refinement, allowing for simplification of care for these patients, but parenteral administration is still required. Therefore, the current completion of phase III trials with selective, predictable and orally available anticoagulants with rapid onset brings promise for a change in paradigm in the treatment of VTE in the next few years. Whereas these efforts will lead to further simplification of the therapy there are also trials conducted to advance the treatment by rapid resolution of the thromboembolism in order to improve long\u2010term outcome. Catheter\u2010directed thrombolysis, perhaps also with thrombus fragmentation and stent insertion, if demonstrated to be successful for the reduction of the postthrombotic syndrome, will only be an alternative for a minority of patients due to the complexity, risks and cost of therapy. This treatment increases the complexity at the same time as new drug regimens offer simplicity. This review focuses on the novel therapies for VTE although the new anticoagulants will also play a major role in the management of arterial disease, which will be briefly presented.<\/jats:p>","DOI":"10.1111\/j.1365-2796.2010.02242.x","type":"journal-article","created":{"date-parts":[[2010,4,20]],"date-time":"2010-04-20T07:18:55Z","timestamp":1271747935000},"page":"109-119","source":"Crossref","is-referenced-by-count":3,"title":["New aspects on treatment modalities for thromboembolic episodes"],"prefix":"10.1111","volume":"268","author":[{"given":"S.","family":"Schulman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,7]]},"reference":[{"key":"e_1_2_10_2_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.08-0658"},{"key":"e_1_2_10_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(60)92299-6"},{"key":"e_1_2_10_4_2","first-page":"1305","article-title":"En kontrolleret unders\u00f8gelse af antikoagulationsbehandlingens effekt ved dyb venetrombose og lungeemboli","volume":"80","author":"Rosenbeck\u2010Hansen JV","year":"1968","journal-title":"Nord Med"},{"key":"e_1_2_10_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199211193272103"},{"key":"e_1_2_10_6_2","doi-asserted-by":"publisher","DOI":"10.1160\/TH05-08-0588"},{"key":"e_1_2_10_7_2","first-page":"507","article-title":"[Prevention of the extension of distal deep venous thrombosis. A randomized controlled trial with a 6\u2010month follow\u2010up]","volume":"88","author":"Belcaro G","year":"1997","journal-title":"Minerva Med"},{"key":"e_1_2_10_8_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.08-0689"},{"key":"e_1_2_10_9_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199603143341102"},{"key":"e_1_2_10_10_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199603143341101"},{"key":"e_1_2_10_11_2","first-page":"CD003074","article-title":"Once versus twice daily LMWH for the initial treatment of venous thromboembolism","author":"Van Dongen CJ","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_10_12_2","first-page":"CD001100","article-title":"Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism","author":"Van Dongen CJJ","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_10_13_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.296.8.935"},{"key":"e_1_2_10_14_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.165.7.733"},{"key":"e_1_2_10_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.2007.01785.x"},{"key":"e_1_2_10_16_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200506-862OC"},{"key":"e_1_2_10_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2009.03705.x"},{"key":"e_1_2_10_18_2","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.15.8.843"},{"key":"e_1_2_10_19_2","doi-asserted-by":"publisher","DOI":"10.1160\/TH09-08-0555"},{"key":"e_1_2_10_20_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa055443"},{"key":"e_1_2_10_21_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-140-11-200406010-00007"},{"key":"e_1_2_10_22_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa035451"},{"key":"e_1_2_10_23_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0803200"},{"key":"e_1_2_10_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2003.00516.x"},{"key":"e_1_2_10_25_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa064247"},{"key":"e_1_2_10_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60168-3"},{"key":"e_1_2_10_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2009.03298.x"},{"key":"e_1_2_10_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2010.03746.x"},{"key":"e_1_2_10_29_2","unstructured":"SargentC.Sanofi\u2010Aventis stops development of two medicines. [WWW document].2009. URLhttp:\/\/www.bloomberg.com\/apps\/news?pid=20601124&sid=aSQKk1p0REko[accessed on 20 March 2010]"},{"key":"e_1_2_10_30_2","doi-asserted-by":"publisher","DOI":"10.1097\/00063198-200109000-00016"},{"key":"e_1_2_10_31_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0905561"},{"key":"e_1_2_10_32_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0906598"},{"key":"e_1_2_10_33_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.08-0674"},{"key":"e_1_2_10_34_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-009-0949-1"},{"key":"e_1_2_10_35_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2009.98"},{"key":"e_1_2_10_36_2","doi-asserted-by":"publisher","DOI":"10.1160\/TH09-05-0287"},{"key":"e_1_2_10_37_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.293.6.681"},{"key":"e_1_2_10_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14841-6"},{"key":"e_1_2_10_39_2","article-title":"Stroke prevention using the oral direct thrombin inhibitor ximelagatran in patients with non\u2010valvular atrial fibrillation (SPORTIF V)","volume":"108","author":"The Executive Steering Committee on behalf of the SPORTIF V Investigators","year":"2003","journal-title":"Circulation"},{"key":"e_1_2_10_40_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa030104"},{"key":"e_1_2_10_41_2","doi-asserted-by":"publisher","DOI":"10.2147\/vhrm.2006.2.1.49"},{"key":"e_1_2_10_42_2","unstructured":"Boehringer Ingelheim.Summary of Product Characteristics: Pradaxa (Dabigatran Etexilate). In:European Medicines Agency ed.2008;1\u201310."},{"key":"e_1_2_10_43_2","volume-title":"Procedural Steps Taken and Scientific Information after the Authorisation","author":"Pradaxa","year":"2009"},{"key":"e_1_2_10_44_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2007.02899.x"},{"key":"e_1_2_10_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.arth.2008.01.132"},{"key":"e_1_2_10_46_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2007.02748.x"},{"key":"e_1_2_10_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61445-7"},{"key":"e_1_2_10_48_2","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1160\/TH08-07-0493","article-title":"Efficacy and safety of dabigatran etexilate for the prevention of venous thromboembolism following total hip or knee arthroplasty. A meta\u2010analysis","volume":"101","author":"Wolowacz SE","year":"2009","journal-title":"Thromb Haemost"},{"key":"e_1_2_10_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2009.01.001"},{"key":"e_1_2_10_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2005.06.011"},{"key":"e_1_2_10_51_2","volume-title":"CHMP Assessment Report for Xarelto","year":"2008"},{"key":"e_1_2_10_52_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0800374"},{"key":"e_1_2_10_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60880-6"},{"key":"e_1_2_10_54_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa076016"},{"key":"e_1_2_10_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60734-0"},{"key":"e_1_2_10_56_2","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V112.11.36.36","article-title":"A pooled analysis of four pivotal studies of rivaroxaban for the prevention of venous thromboembolism after orthopaedic surgery: effect on symptomatic venous thromboembolism, death, and bleeding","volume":"112","author":"Turpie AG","year":"2008","journal-title":"Blood"},{"key":"e_1_2_10_57_2","article-title":"Enoxaparin versus dabigatran etexilate or rivaroxaban for thromboprophylaxis after hip or knee arthroplasty","volume":"5","author":"Huisman MV","year":"2009","journal-title":"J Thromb Haemost"},{"key":"e_1_2_10_58_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2009.11.025"},{"key":"e_1_2_10_59_2","doi-asserted-by":"crossref","first-page":"LBA\u20102","DOI":"10.1182\/blood.V114.22.LBA-2.LBA-2","article-title":"Once\u2010daily oral rivaroxaban versus placebo in the long\u2010term prevention of recurrent symptomatic venous thromboembolism: the Einstein\u2010Extension study","volume":"114","author":"Buller HR","year":"2009","journal-title":"Blood"},{"key":"e_1_2_10_60_2","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.108.023143"},{"key":"e_1_2_10_61_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)62125-5"},{"key":"e_1_2_10_62_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0810773"},{"key":"e_1_2_10_63_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2009.07.035"},{"key":"e_1_2_10_64_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2009.08.026"},{"key":"e_1_2_10_65_2","first-page":"CD002783","article-title":"Thrombolysis for acute deep vein thrombosis","author":"Watson LI","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_10_66_2","doi-asserted-by":"publisher","DOI":"10.1053\/ejvs.2002.1665"},{"key":"e_1_2_10_67_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2007.07.010"},{"key":"e_1_2_10_68_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2009.03464.x"},{"key":"e_1_2_10_69_2","unstructured":"VedanthamS GoldhaberSZ.Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter\u2010Directed Thrombolysis (ATTRACT). URLhttp:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT00790335?term=Vedantham&rank=1[accessed on 24 March 2010]"},{"key":"e_1_2_10_70_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.08-0673"},{"key":"e_1_2_10_71_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2296-8-6"}],"container-title":["Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2796.2010.02242.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2796.2010.02242.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T06:23:05Z","timestamp":1698906185000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2796.2010.02242.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":70,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["10.1111\/j.1365-2796.2010.02242.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2796.2010.02242.x","archive":["Portico"],"relation":{},"ISSN":["0954-6820","1365-2796"],"issn-type":[{"value":"0954-6820","type":"print"},{"value":"1365-2796","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7]]}}}